Sign up to The Irish Times Archive (1859 - 2008)My Account »
Mon 01 Jan 2009Azur Pharma agrees US licensing deal
AZUR PHARMA Limited, the Irish pharmaceutical company founded by former Élan executive Seamus Mulligan in 2005, has licensed the exclusive US marketing rights for four drugs used for the treatment of conditions primarily relating to the central nervous system from UCB, a quoted pharmaceutical company.
The company said the deal substantially broadens the range of products now held by it and allows it to leverage the nationwide sales force it has built in the US.
Choose a Subscription type - required
